
Privacy notice | Accessibility statement | Terms and conditions | Login | Contact |
UK data driving real-world evidence
Bibliography
Research using CPRD data has informed drug safety guidance and clinical practice and resulted in over 2,700 peer-reviewed publications. The CPRD bibliography is updated on a monthly basis (last updated 6 April 2021) and papers are listed below and in the PDF below.
If you have published papers using CPRD data which are not included in this list, please contact us at enquiries@cprd.com so that we can update the bibliography.
Download:
(PDF, 5MB, 226 pages)This work uses data provided by patients and collected by the NHS as part of their care and support. CPRD encourages researchers to use this citation in all publications using CPRD data. Find out more about acknowledging the use of patient data at the Understanding Patient Data website.
“Infectious Disease Burden and the Risk of Alzheimer's Disease: A Population-Based Study”, J Alzheimers Dis, 2021.
, “Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018”, J Affect Disord, vol. 287, pp. 19-25, 2021.
, , “The Association between Oral Anticoagulants and Cancer Incidence among Individuals with Nonvalvular Atrial Fibrillation”, Thromb Haemost, 2020.
, “Beta 2 agonists and the incidence of Parkinson's disease”, Am J Epidemiol, 2020.
, , “Association of Aripiprazole With the Risk for Psychiatric Hospitalization, Self-harm, or Suicide”, JAMA Psychiatry, 2019.
, “Cardiovascular and cerebrovascular safety of testosterone replacement therapy among aging men with low testosterone levels: a cohort study.”, Am J Med, 2019.
, “Degree of serotonin reuptake inhibition of antidepressants and ischemic risk: A cohort study”, Neurology, vol. 93, pp. e1010-e1020, 2019.
, , “Comparative effect of statins on the risk of incident Alzheimer disease”, Neurology, vol. 90, pp. e179-e187, 2018.
, “Comparative effectiveness of novel oral anticoagulants in UK patients with non-valvular atrial fibrillation and chronic kidney disease: a matched cohort study”, BMJ Open, vol. 8, p. e019638, 2018.
, “Dipeptidyl peptidase-4 inhibitors and incidence of inflammatory bowel disease among patients with type 2 diabetes: population based cohort study”, Bmj, vol. 360, p. k872, 2018.
, “Use of Dipeptidyl Peptidase-4 Inhibitors and New-onset Rheumatoid Arthritis in Patients with Type 2 Diabetes”, Epidemiology, vol. 29, pp. 904-912, 2018.
, “Association of Selective Serotonin Reuptake Inhibitors With the Risk for Spontaneous Intracranial Hemorrhage”, JAMA Neurol, vol. 74, pp. 173-180, 2017.
, “Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism”, Pharmacoepidemiol Drug Saf, vol. 26, pp. 554-560, 2017.
, “Trends in the prescription of novel oral anticoagulants in UK primary care”, Br J Clin Pharmacol, vol. 83, pp. 2096-2106, 2017.
, “Prescribing trends of attention-deficit hyperactivity disorder (ADHD) medications in UK primary care, 1995-2015”, Br J Clin Pharmacol, vol. 82, pp. 858-68, 2016.
, “Ventricular tachyarrhythmia and sudden cardiac death with domperidone use in Parkinson's disease”, Br J Clin Pharmacol, vol. 82, pp. 461-72, 2016.
, “Antiepileptic drugs and the risk of ischaemic stroke and myocardial infarction: a population-based cohort study”, BMJ Open, vol. 5, p. e008365, 2015.
, “Serotonin-Norepinephrine Reuptake Inhibitors and the Risk of AKI: A Cohort Study of Eight Administrative Databases and Meta-Analysis”, Clin J Am Soc Nephrol, vol. 10, pp. 1716-22, 2015.
, “Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study”, Menopause, vol. 21, pp. 1023-6, 2014.
, “Initiation of warfarin in patients with atrial fibrillation: early effects on ischaemic strokes”, Eur Heart J, vol. 35, pp. 1881-7, 2014.
, “The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation”, Thromb Haemost, vol. 109, pp. 431-9, 2013.
, “Dopamine agonist use and the risk of heart failure”, Pharmacoepidemiol Drug Saf, vol. 21, pp. 34-41, 2012.
, “A net clinical benefit analysis of warfarin and aspirin on stroke in patients with atrial fibrillation: a nested case-control study”, BMC Cardiovasc Disord, vol. 12, p. 49, 2012.
, “Pramipexole use and the risk of pneumonia”, BMC Neurol, vol. 12, p. 113, 2012.
, “Androgen-deprivation therapy and the risk of stroke in patients with prostate cancer”, Eur Urol, vol. 60, pp. 1244-50, 2011.
, “The use of atypical antipsychotics and the risk of breast cancer”, Breast Cancer Res Treat, vol. 129, pp. 541-8, 2011.
, “Hormone replacement therapy and the risk of venous thromboembolism: a population-based study”, J Thromb Haemost, vol. 8, pp. 979-86, 2010.
, “Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study”, Bmj, vol. 340, p. c2519, 2010.
, “Hormone replacement therapy use and the risk of stroke”, Maturitas, vol. 61, pp. 305-9, 2008.
,